Afya (NASDAQ:AFYA) Downgraded by Zacks Investment Research to Hold

Afya (NASDAQ:AFYA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, Zacks.com reports.

According to Zacks, “Afya Limited is a medical education group primarily in Brazil. Afya Limited is based in NEW YORK. “

Several other research analysts have also recently issued reports on the company. UBS Group upgraded Afya from a “neutral” rating to a “buy” rating in a research report on Thursday, April 15th. Morgan Stanley lowered Afya from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $32.00 to $28.50 in a report on Wednesday. Finally, TheStreet raised Afya from a “d+” rating to a “c-” rating in a report on Monday, June 14th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $29.78.

NASDAQ AFYA traded down $0.41 on Thursday, reaching $23.78. The stock had a trading volume of 3,642 shares, compared to its average volume of 115,870. The company has a debt-to-equity ratio of 0.17, a quick ratio of 2.10 and a current ratio of 2.12. Afya has a 12-month low of $18.48 and a 12-month high of $29.01. The company’s 50-day moving average is $24.98. The firm has a market capitalization of $2.22 billion, a PE ratio of 39.63, a P/E/G ratio of 1.03 and a beta of 1.33.

Afya (NASDAQ:AFYA) last released its quarterly earnings results on Wednesday, May 26th. The company reported $1.16 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.56 by ($0.40). Afya had a return on equity of 11.73% and a net margin of 22.99%. The company had revenue of $72.15 million for the quarter, compared to analysts’ expectations of $72.96 million. On average, equities research analysts anticipate that Afya will post 0.99 EPS for the current year.

Institutional investors have recently added to or reduced their stakes in the company. Jupiter Asset Management Ltd. purchased a new position in shares of Afya in the 1st quarter worth about $5,120,000. TimesSquare Capital Management LLC raised its holdings in shares of Afya by 31.8% in the 1st quarter. TimesSquare Capital Management LLC now owns 892,000 shares of the company’s stock worth $16,582,000 after purchasing an additional 215,200 shares during the period. Employees Retirement System of Texas purchased a new position in shares of Afya in the 1st quarter worth about $1,078,000. Amundi Pioneer Asset Management Inc. raised its holdings in shares of Afya by 2.9% during the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 427,676 shares of the company’s stock valued at $10,820,000 after buying an additional 12,085 shares during the period. Finally, Norges Bank purchased a new stake in shares of Afya during the 4th quarter valued at about $13,001,000. Institutional investors own 29.47% of the company’s stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Featured Article: What sectors are represented in the FTSE 100 index?

Get a free copy of the Zacks research report on Afya (AFYA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.